BIT
HTGM

BlackRock Institutional Trust’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

BlackRock Institutional Trust’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43
Closed -$17K – 3906
2016
Q3 		$17K Sell
43
-3
-7% -$1.34K ﹤0.01% 3822
2016
Q2 		$23K Sell
46
-18
-28% -$9.14K ﹤0.01% 3812
2016
Q1 		$33K Sell
64
-9
-12% -$5.03K ﹤0.01% 3823
2015
Q4 		$57K Hold
73
– – ﹤0.01% 3805
2015
Q3 		$100K Hold
73
– – ﹤0.01% 3731
2015
Q2 		$146K Buy
+73
New +$186K ﹤0.01% 3674

Other funds holding HTGM

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return
IF
Ironwood Financial Tucson, Arizona $639M AUM 19.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's HTGM Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2016, closing a stake of 43 shares — an estimated $17K sold.

BlackRock Institutional Trust first reported a position in HTGM in Q2 2015 and held it in 6 quarters. The position peaked at $146K in Q2 2015. 13 funds tracked by Wall St. Rank hold HTGM as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 43 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2016, an estimated $17K.
  • BlackRock Institutional Trust first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
  • BlackRock Institutional Trust's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $146K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.